Showing results (1-10 of 111) with videos related to
Sort By:
Pageof 12
British Journal of Cancer|October 1, 1994
Lack of effect of interferon alpha 2a upon fluorouracil pharmacokineticsM T Seymour, N Patel, A Johnston, et al.British Journal of Cancer|October 1, 1994
Double modulation of 5-fluorouracil with interferon alpha 2a and high-dose leucovorin: a phase I and II studyM T Seymour, P W Johnson, M R Hall, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Epirubicin, cisplatin and oral UFT with leucovorin ('ECU'): a phase I-II study in patients with advanced upper gastrointestinal tract cancerM T Seymour, J T Dent, D Papamichael, et al.British Journal of Cancer|September 1, 1991
A less toxic regimen of 5-fluorouracil and high-dose folinic acid for advanced gastrointestinal adenocarcinomasP W Johnson, P I Thompson, M T Seymour, et al.British Journal of Hospital Medicine|July 1, 1987
Talking about cancer: how much is too much?M L SlevinBritish Journal of Cancer|January 1, 1994
Protracted oral etoposide in epithelial ovarian cancer: a phase II study in patients with relapsed or platinum-resistant diseaseM T Seymour, J L Mansi, C J Gallagher, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 1, 1985
Allopurinol mouthwashes and 5-fluorouracil induced oral toxicityP I Clark, M L SlevinCancer Chemotherapy and Pharmacology|January 1, 1994
Schedule-dependent topoisomerase II-inhibiting drugsS P Joel, M L SlevinClinical Pharmacokinetics|April 1, 1987
The clinical pharmacology of etoposide and teniposideP I Clark, M L SlevinPageof 12